Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q7SR
|
|||
| Former ID |
DIB006099
|
|||
| Drug Name |
Cervarix
|
|||
| Synonyms |
GSK-580299; MEDI-501; MEDI-503; MEDI-504; MEDI-517; HPV vaccine, MedImmune/GSK; HPV vaccine, MedImmune/SB; MEDI-503 + MEDI-504, MedImmune/GSK; Human papillomavirus vaccine (HPV-16 + HPV-18), MedImmune/GSK; 580299
Click to Show/Hide
|
|||
| Indication | Human papillomavirus infection [ICD-11: 1A9Y; ICD-9: 078.1079.4] | Approved | [1], [2] | |
| Company |
Medlmmune LLC
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT00534638) Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.